Topiramate selectively attenuates nicotine-induced increases in monoamine release.
Schiffer
W K
WK
Chemistry Department, Brookhaven National Laboratory, Upton, New York 11973, USA. wynne@bnl.gov
Gerasimov
M R
MR
Marsteller
D A
DA
Geiger
J
J
Barnett
C
C
Alexoff
D L
DL
Dewey
S L
SL
D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology*; D015306:Biogenic Monoamines / Q000378:metabolism*; D001923:Brain Chemistry / Q000187:drug effects; D004298:Dopamine / Q000378:metabolism; D004347:Drug Interactions; D005632:Fructose / Q000031:analogs & derivatives* / Q000494:pharmacology*; D017551:Microdialysis; D009538:Nicotine / Q000494:pharmacology*; D018722:Nicotinic Agonists / Q000494:pharmacology*; D009638:Norepinephrine / Q000378:metabolism; D012701:Serotonin / Q000378:metabolism; D000077236:Topiramate
D000927:Anticonvulsants; D015306:Biogenic Monoamines; D018722:Nicotinic Agonists; D000077236:Topiramate; D005632:Fructose; D012701:Serotonin; D009538:Nicotine; D004298:Dopamine; D009638:Norepinephrine